Trials / Conditions / Unresectable Stage III Melanoma
Unresectable Stage III Melanoma
4 registered clinical trials studyying Unresectable Stage III Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimet NCT03235245 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Unknown | Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy NCT03353402 | Sheba Medical Center | Phase 1 |
| Completed | RTA 408 Capsules in Patients With Melanoma - REVEAL NCT02259231 | Biogen | Phase 1 / Phase 2 |
| Terminated | Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects NCT01605162 | Eisai Inc. | Phase 2 |